Medicina regenerativa no esporte: potencial e limitações das células-tronco na recuperação de lesões tendíneas e musculares em atletas
Revista ft · 2026-07-24 · 30 (160) · 01-17
DOI: 10.69849/evm23261 ↗At a glance
Journal article in Revista ft, published online on 2026-07-24. Written by Maria Clara Mansur Zanetti and 7 co-authors. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
Introduction
Regenerative medicine in sports, with a focus on mesenchymal stem cells (MSCs), offers innovative approaches for the treatment of musculoskeletal injuries in athletes by modulating inflammation and promoting tissue regeneration.
Objectives
To analyze the scientific literature published between 2021 and 2026 on the potential and limitations of stem cells in the recovery of tendon and muscle injuries in athletes, identifying key findings, trends, and research gaps.
Method
A descriptive and analytical narrative review was conducted through searches in LILACS, MEDLINE/PubMed, SCOPUS, Web of Science, and Google Scholar using descriptors such as "Stem Cells" and "Regenerative Medicine." Inclusion criteria comprised full-text articles published in Portuguese, English, or Spanish. Duplicate records and studies lacking methodological rigor were excluded.
Discussion
MSC therapy has emerged as a cornerstone of regenerative medicine, acting through cellular differentiation, paracrine signaling, immunomodulation, and extracellular matrix remodeling. Clinical applications have demonstrated efficacy in the treatment of osteoarthritis, tendon injuries, muscle injuries, and bone defects, although results remain heterogeneous. In osteochondral lesions, MSCs have shown superior outcomes compared with platelet-rich plasma (PRP). Recent advances include the use of exosomes and genetically modified MSCs. However, important limitations remain, including study heterogeneity, biological risks, high costs, and the lack of long-term data. Existing gaps highlight the need for standardized protocols and robust clinical trials.
Conclusion
MSCs represent a promising therapeutic strategy in sports medicine; however, current evidence remains insufficient to support standardized clinical use. Their routine incorporation into clinical practice depends on further robust, standardized, and long-term clinical studies to confirm their efficacy and safety in athletes.
Cite
APA
Zanetti, M. C. M., Tavares, A. L. K., Fiorotti, A. A., Terra, B. L., Campos, G. S. M., Guimarães, I. S., Kill, J. P., & Sobral, D. R. (2026). Medicina regenerativa no esporte: potencial e limitações das células-tronco na recuperação de lesões tendíneas e musculares em atletas. Revista ft, 30(160), 01-17. https://doi.org/10.69849/evm23261
Vancouver
Zanetti MCM, Tavares ALK, Fiorotti AA, Terra BL, Campos GSM, Guimarães IS, et al. Medicina regenerativa no esporte: potencial e limitações das células-tronco na recuperação de lesões tendíneas e musculares em atletas. Revista ft. 2026;30(160):01-17. doi:10.69849/evm23261
BibTeX
@article{Zanetti2026,
author = {Zanetti, Maria Clara Mansur and Tavares, Ana Luiza Kale and Fiorotti, Arthur Alves and Terra, Bruno Lima and Campos, Gabriela Santos Mendonça and Guimarães, Isadora Sarmento and Kill, João Pedro and Sobral, Diego Rangel},
title = {Medicina regenerativa no esporte: potencial e limitações das células-tronco na recuperação de lesões tendíneas e musculares em atletas},
journal = {Revista ft},
year = {2026},
volume = {30},
number = {160},
pages = {01--17},
doi = {10.69849/evm23261}
}
EUVIMED